SCHEMBL4379669

SCHEMBL4379669

CC=CCN(CCC12CC3CC(CC(C3)C1)C2)C(=O)NCCCc1ccncc1.CCCN(CCCC12CC3CC(CC(C3)C1)C2)C(=O)NCCCc1ccncc1

nearest known ligand 0.39

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
ALDH1A1 P00352 4/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
HTT P42858 2/20 0.36
GAA P10253 1/20 0.36
CYP19A1 P11511 2/20 0.35
CYP17A1 P05093 1/20 0.35
EPHX2 P34913 7/20 0.35
EPHX1 P07099 1/20 0.35
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1677575 0.93 P2RX7 (0.44) P2RX7SMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL1677574 0.93 P2RX7 (0.44) P2RX7SMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL1677672 0.91 P2RX7 (0.46) P2RX7SMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL1677703 0.90 P2RX7 (0.46) P2RX7SMN1; SMN2ALDH1A1MEN1KMT2A
Hydrochloric Acid SCHEMBL1678012 0.89 P2RX7 (0.46) P2RX7SMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL1677662 0.88 P2RX7 (0.45) P2RX7SMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL1677991 0.88 P2RX7 (0.45) P2RX7SMN1; SMN2ALDH1A1MEN1KMT2A
Phosphoric Acid SCHEMBL1678020 0.88 P2RX7 (0.43) P2RX7SMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL1677690 0.87 P2RX7 (0.46) P2RX7SMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL1678249 0.87 P2RX7 (0.46) P2RX7SMN1; SMN2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1743885-B1 1-[(adamantyl)alkyl]-3-[(pyridinyl)alkyl]urea compounds as TNF-.alpha inhibitors useful for autoimmune diseases SANTEN PHARMACEUTICAL CO LTD (JP) 2009-11-11 EP disclosed